Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 20, 2026 12:35 ET | Source: Research and Markets

Arrayed CRISPR Screening Market Presents Lucrative Opportunities Through 2026-2030: Total Revenue to Grow by $1.64 Billion at 17.7% CAGR

Dublin, April 20, 2026 (GLOBE NEWSWIRE) -- The "Arrayed Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Report 2026" has been added to ResearchAndMarkets.com's...
April 20, 2026 03:17 ET | Source: Mordor Intelligence

Urology Devices Market to Reach $58.63 Billion by 2031 with Robotic Urologic Surgery Systems Projected to Expand at a 10.31% CAGR, Reports Mordor Intelligence

Hyderabad, India, April 20, 2026 (GLOBE NEWSWIRE) -- According to Mordor Intelligence, the urology devices market size is projected to increase from USD 39.65 billion in 2025 to USD 42.32 billion in...
April 13, 2026 10:27 ET | Source: Research and Markets

B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Report 2026 - Worth $18.75 Billion in 2026, the Market is Expected to Reach $44.29 Billion by 2030

Dublin, April 13, 2026 (GLOBE NEWSWIRE) -- The "B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Report 2026" has been added to ResearchAndMarkets.com's offering. The report provides...
April 07, 2026 03:31 ET | Source: Mordor Intelligence

Influenza Vaccine Market Forecast 2031: Quadrivalent Vaccines Held 71.68% Share in 2025, Says a Mordor Intelligence Report

North America led the influenza vaccines market with a 47.10% share in 2025, while Asia-Pacific is projected to grow fastest at a 7.92% CAGR through 2031.
April 02, 2026 11:39 ET | Source: Research and Markets

Stomach Cancer Market Insights, Trends and Innovations Worldwide, 2026-2030 & 2035

Dublin, April 02, 2026 (GLOBE NEWSWIRE) -- The "Stomach Cancer Market Report 2026" has been added to ResearchAndMarkets.com's offering. This report provides insights into market dynamics, trends,...
April 02, 2026 09:49 ET | Source: Research and Markets

Glioblastoma Multiforme Market Intelligence Report 2026-2030 & 2035: Advanced Targeted Drugs Propel Industry Growth

Dublin, April 02, 2026 (GLOBE NEWSWIRE) -- The "Glioblastoma Multiforme Market Report 2026" has been added to ResearchAndMarkets.com's offering.The glioblastoma multiforme market has demonstrated...
April 02, 2026 07:01 ET | Source: Research and Markets

Low-Grade Glioma Market Trends and Investment Opportunities Through 2030 & 2035: Regional Insights for Trametinib, Dabrafenib, Ivosidenib, and Mirdametinib

Dublin, April 02, 2026 (GLOBE NEWSWIRE) -- The "Low-Grade Glioma Market Report 2026" has been added to ResearchAndMarkets.com's offering. The global low-grade glioma market is experiencing a...
April 01, 2026 05:20 ET | Source: Research and Markets

Advanced Renal Cell Carcinoma Treatment Market to Grow by $3.1 Billion During 2026-2030: Global Industry Assessment Featuring Pfizer, Merck & Co., Bristol-Myers Squibb, AstraZeneca, Novartis and More

Dublin, April 01, 2026 (GLOBE NEWSWIRE) -- The "Advanced Renal Cell Carcinoma Treatment Market Report 2026" has been added to ResearchAndMarkets.com's offering. The report outlines...
March 30, 2026 06:33 ET | Source: Research and Markets

Advanced Melanoma Markets and Companies 2026-2030: Cumulative Revenue to Grow by $1.87 Billion

Dublin, March 30, 2026 (GLOBE NEWSWIRE) -- The "Advanced Melanoma Market Report 2026" has been added to ResearchAndMarkets.com's offering. The advanced melanoma market has demonstrated robust...
March 30, 2026 05:51 ET | Source: Research and Markets

Pancreatic Adenocarcinoma Treatment Market to Grow at 13% CAGR During 2026-2030, Led by Pfizer, Roche, Merck & Co., Sanofi, Bristol-Myers Squibb, AstraZeneca, Novartis, and GlaxoSmithKline

Dublin, March 30, 2026 (GLOBE NEWSWIRE) -- The "Pancreatic Adenocarcinoma Treatment Market Report 2026" has been added to ResearchAndMarkets.com's offering. The pancreatic adenocarcinoma...